Share-based Payment Arrangement, Expense of ELITE PHARMACEUTICALS INC /NV/ from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $45,096, a 36% decline year-over-year.
  • ELITE PHARMACEUTICALS INC /NV/ Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $199,672, a 12% decline year-over-year.
  • ELITE PHARMACEUTICALS INC /NV/ annual Share-based Payment Arrangement, Expense for 2024 was $227,565, a 42% increase from 2023.
  • ELITE PHARMACEUTICALS INC /NV/ annual Share-based Payment Arrangement, Expense for 2023 was $159,921, a 307% increase from 2022.
  • ELITE PHARMACEUTICALS INC /NV/ annual Share-based Payment Arrangement, Expense for 2022 was $39,325, a 174% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $199,672 $45,096 -$25,482 -36% 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q3
Q3 2025 $225,154 $49,918 -$2,411 -4.6% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 $227,565 $52,329 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 $227,565 $52,329 $0 0% 01 Jan 2025 31 Mar 2025 10-K 30 Jun 2025 2025 FY
Q4 2024 $227,565 $70,578 +$20,763 +42% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q3
Q3 2024 $206,802 $52,329 +$9,552 +22% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q2
Q2 2024 $197,250 $52,329 +$37,329 +249% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q1 2024 $159,921 $52,329 +$37,329 +249% 01 Jan 2024 31 Mar 2024 10-K 30 Jun 2025 2025 FY
Q4 2023 $122,592 $49,815 +$36,785 +282% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2025 Q3
Q3 2023 $85,807 $42,777 +$36,804 +616% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q2
Q2 2023 $49,003 $15,000 +$9,678 +182% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2025 Q1
Q1 2023 $39,325 $15,000 +$11,264 +301% 01 Jan 2023 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 $28,061 $13,030 +$9,400 +259% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q3
Q3 2022 $18,661 $5,973 +$1,797 +43% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q2
Q2 2022 $16,864 $5,322 +$2,511 +89% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2024 Q1
Q1 2022 $14,353 $3,736 -$184 -4.7% 01 Jan 2022 31 Mar 2022 10-K 29 Jun 2023 2023 FY
Q4 2021 $14,537 $3,630 +$1,979 +120% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q3
Q3 2021 $12,558 $4,176 +$2,087 +100% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q2
Q2 2021 $10,471 $2,811 -$2,710 -49% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2023 Q1
Q1 2021 $13,181 $3,920 -$4,660 -54% 01 Jan 2021 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 $17,841 $1,651 -$10,151 -86% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q3
Q3 2020 $27,992 $2,089 -$13,433 -87% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2022 Q2
Q2 2020 $41,425 $5,521 -$20,673 -79% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2022 Q1
Q1 2020 $62,098 $8,580 -$18,148 -68% 01 Jan 2020 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q4 2019 $80,246 $11,802 -$24,745 -68% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021 2021 Q3
Q3 2019 $104,991 $15,522 -$21,023 -58% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2021 Q2
Q2 2019 $126,014 $26,194 -$10,355 -28% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2021 Q1
Q1 2019 $136,369 $26,728 -$9,306 -26% 01 Jan 2019 31 Mar 2019 10-K 29 Jun 2020 2020 FY
Q4 2018 $145,675 $36,547 -$1,414 -3.7% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q3
Q3 2018 $147,089 $36,545 -$36,852 -50% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2020 Q2
Q2 2018 $183,941 $36,549 -$60,812 -62% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2020 Q1
Q1 2018 $244,753 $36,034 -$62,967 -64% 01 Jan 2018 31 Mar 2018 10-K 21 Jun 2019 2019 FY
Q4 2017 $307,720 $37,961 -$46,824 -55% 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019 2019 Q3
Q3 2017 $354,544 $73,397 -$11,388 -13% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2019 Q2
Q2 2017 $365,932 $97,361 +$7,977 +8.9% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2019 Q1
Q1 2017 $357,955 $99,001 +$12,135 +14% 01 Jan 2017 31 Mar 2017 10-K 14 Jun 2018 2018 FY
Q4 2016 $345,820 $84,785 +$9,760 +13% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018 2018 Q3
Q3 2016 $336,060 $84,785 +$3,793 +4.7% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q2
Q2 2016 $332,267 $89,384 -$1,095 -1.2% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2018 Q1
Q1 2016 $333,362 $86,866 -$6,531 -7% 01 Jan 2016 31 Mar 2016 10-K 14 Jun 2018 2018 FY
Q4 2015 $339,893 $75,025 -$14,480 -16% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017 2017 Q3
Q3 2015 $354,373 $80,992 +$27,511 +51% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2017 Q2
Q2 2015 $326,862 $90,479 +$66,817 +282% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2017 Q1
Q1 2015 $260,045 $93,397 01 Jan 2015 31 Mar 2015 10-K 14 Jun 2017 2017 FY
Q4 2014 $89,505 +$65,843 +278% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q3
Q3 2014 $53,481 01 Jul 2014 30 Sep 2014 10-Q 30 Dec 2015 2016 Q2
Q2 2014 $23,662 01 Apr 2014 30 Jun 2014 10-Q 30 Dec 2015 2016 Q1
Q4 2013 $23,662 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015 2015 Q3

ELITE PHARMACEUTICALS INC /NV/ Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $227,565 +$67,644 +42% 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025 2025 FY
2023 $159,921 +$120,596 +307% 01 Apr 2023 31 Mar 2024 10-K 30 Jun 2025 2025 FY
2022 $39,325 +$24,972 +174% 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024 2024 FY
2021 $14,353 +$1,172 +8.9% 01 Apr 2021 31 Mar 2022 10-K 29 Jun 2023 2023 FY
2020 $13,181 -$48,917 -79% 01 Apr 2020 31 Mar 2021 10-K 29 Jun 2022 2022 FY
2019 $62,098 -$74,271 -54% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021 2021 FY
2018 $136,369 -$108,384 -44% 01 Apr 2018 31 Mar 2019 10-K 29 Jun 2020 2020 FY
2017 $244,753 -$113,202 -32% 01 Apr 2017 31 Mar 2018 10-K 21 Jun 2019 2019 FY
2016 $357,955 +$24,593 +7.4% 01 Apr 2016 31 Mar 2017 10-K 14 Jun 2018 2018 FY
2015 $333,362 +$73,317 +28% 01 Apr 2015 31 Mar 2016 10-K 14 Jun 2018 2018 FY
2014 $260,045 +$177,098 +214% 01 Apr 2014 31 Mar 2015 10-K 14 Jun 2017 2017 FY
2013 $82,947 01 Apr 2013 31 Mar 2014 10-K 15 Jun 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.